文献速递主动脉疾病

EVAR后伴囊体扩大的II型内漏外科治疗模式与临床结局

Surgical treatment patterns and clinical outcomes of patients treated for expanding aneurysm sacs with type II endoleaks after endovascular aneurysm repair.
PubMed 文献 · J Vasc Surg · 2020-06-29

该回顾性研究分析了2006至2017年间56例因EVAR后II型内漏伴囊体扩大接受干预的患者,共进行119次干预,技术成功率为90%。尽管技术成功率高,但内漏复发常见,59%患者需进一步干预,仅25%患者在没有进一步再干预的情况下达到临床成功。约21%患者后续影像发现近端或远端密封区丢失,需延长移植物以稳定囊体。

要点

  • EVAR后II型内漏伴囊体扩大干预技术成功率高,但内漏复发和再干预常见。
  • 约五分之一患者在接受II型内漏治疗前评估中发现近端或远端密封区丢失。
  • 治疗前应全面评估所有类型内漏,以避免无效干预。

核心结论

  • 尽管T2EL治疗技术成功率高,但内漏复发常见,常需多次干预以稳定囊体大小。
  • 约20%接受T2EL治疗的患者在进一步评估时发现近端或远端密封区丢失,需修复以达到囊体稳定。

研究设计与样本

  • 回顾性综述,纳入2006年至2017年在一家学术医疗中心因EVAR后II型内漏伴囊体扩大接受治疗的所有患者,共56例,接受119次干预。

主要发现

  • 56例患者共接受119次干预,其中107次(90%)技术成功。
  • 从EVAR到首次T2EL手术的中位时间为37个月(IQR 17-56个月),首次T2EL手术后中位随访27个月(IQR 10-51个月)。
  • 10例(18%)患者最终接受移植物切除或囊体切开并缝合内漏来源。

临床怎么用

  • 对于EVAR后II型内漏伴囊体扩大的患者,治疗前应全面评估所有类型内漏,包括近端和远端密封区,以确保适当治疗并减少无效干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Persistent type II endoleaks (T2ELs) after endovascular aneurysm repair (EVAR) with sac growth have been associated with adverse events, including rupture. Whereas intervention in the presence of aneurysm growth has become an accepted treatment paradigm for T2ELs, the efficacy and clinical success of such interventions remain unclear. Therefore, we examined the treatment patterns and clinical outcomes of patients undergoing T2EL interventions after EVAR. METHODS: We performed a retrospective review of all patients treated for expanding aneurysm sacs with T2ELs after EVAR at an academic medical center between 2006 and 2017. The primary outcomes assessed were need for repeated intervention; intervention types; and achievement of clinical success, defined as stable aneurysm sac size on computed tomography angiography after treatment. RESULTS: Fifty-six patients underwent 119 interventions, of which 107 (90%) were technically successful. The median time from EVAR to index T2EL procedure was 37 months (interquartile range, 17-56 months), and the median follow-up time from first T2EL procedure was 27 months (interquartile range, 10-51 months). The most common index procedure was transarterial lumbar embolization (64%), followed by transarterial inferior mesenteric artery (20%), transcaval (14%), and translumbar embolization (1.8%). Thirty-three (59%) patients required further procedures for persistent aneurysm sac expansion. For subsequent T2EL interventions, the most common endovascular procedure was transarterial lumbar embolization (21%), followed by transcaval (21%), translumbar (11%), and transarterial inferior mesenteric artery embolization (8.6%). Twelve patients (21%) were found to have loss of proximal or distal seal on subsequent imaging and required graft extensions to stabilize aneurysm sac size. Ten patients (18%) ultimately underwent graft explantation or sacotomy with oversewing of the endoleak source. Freedom from any endoleak-related reintervention was 57% at 1 year and 36% at 3 years. Freedom from open treatment was 93% at 1 year and 82% at 3 years. Of the 44 patients with ≥6-month follow-up, 39 (89%) achieved clinical success. However, only 11 patients (25%) achieved clinical success without any further reintervention, and 29 patients (66%) achieved clinical success without open treatment. CONCLUSIONS: Despite high technical success, endoleak recurrence after T2EL treatment is common, and multiple interventions are often needed to stabilize aneurysm sac size in patients diagnosed with T2EL-associated sac growth. Notably, one in five patients treated for T2ELs was discovered, on further evaluation, to have proximal or distal seal zone loss that necessitated repair to achieve sac stability. Thus, thorough assessment of all endoleak types should be performed in patients with T2ELs associated with sac growth before T2EL treatment to ensure appropriate care and to minimize ineffective interventions.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Wu WW, Swerdlow NJ, Dansey K, et al. Surgical treatment patterns and clinical outcomes of patients treated for expanding aneurysm sacs with type II endoleaks after endovascular aneurysm repair. J Vasc Surg. 2020. PMID: 32615284. doi:10.1016/j.jvs.2020.05.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。